Escalade, Incorporated
NASDAQ:ESCALeisure
+$0.23 today
- Market cap
- $297.29M
- Beta
- 0.60
- P/E (TTM)
- 16.3
- EPS (TTM)
- $1.12
- Dividend yield
- 3.28%
Volume 0.06M
Average 0.04M
ESCA Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Escalade, IncorporatedNASDAQ: ESCA
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0. Over 3 fiscal years it compounded at +5.8% a year.
Context
- Research & development amounted to 1.3% of revenue in FY2025, up 1.3 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 3.2M USD
- Year-over-year change
- —
- 4-year CAGR
- +12.5%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.2M | — |
| FY2024 | 2024-12-31 | 0 | -100.0% |
| FY2023 | 2023-12-31 | 3.1M | +14.8% |
| FY2022 | 2022-12-31 | 2.7M | +35.0% |
| FY2021 | 2021-12-31 | 2M | — |
Research & Development vs competitors
How ESCA compares with its peers on the latest reported figures
- ESCA's LTM Mar 2026 research & development of $0 is the 2nd highest of the 8 companies compared; the peer median is $0.
- Its year-over-year change of -100.0% is the 2nd highest of 3, against a peer median of -99.3%.
- Research & development amounts to 0.0% of revenue for ESCA, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
AIIORobo.ai Inc. | FY2025 | $64K | -98.6% | -84.1% | 6.7% |
| LTM Mar 2026 | $0 | -100.0% | +5.8% | 0.0% | |
| LTM Feb 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
NOMANomadar Corp. | LTM Mar 2026 | $0 | — | — | 0.0% |
| Peer median (excluding ESCA) | $0 | -99.3% | -84.1% | 0.0% | |
Competitors are the stored peer set for ESCA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 313.61M | 313.76M | 263.57M | 251.51M | 240.16M |
| Cost of Revenue | 236.48M | 240.12M | 201.8M | 189.31M | 177.81M |
| Gross Profit | 77.13M | 73.64M | 61.77M | 62.2M | 62.35M |
| Gross Margin | 24.6% | 23.5% | 23.4% | 24.7% | 26.0% |
| Research & Development | 2M | 2.7M | 3.1M | 0 | 3.2M |
| Selling, General & Admin | 43.37M | 44.77M | 41.48M | 43.3M | 40.43M |
| Operating Expenses | 45.23M | 47.32M | 43.96M | 42.2M | 43.63M |
| Depreciation & Amortization | 4.84M | 6.06M | 5.67M | 6.04M | 5.06M |
| EBITDA | 36.89M | 32.46M | 23.51M | 26.12M | 23.92M |
| EBITDA Margin | 11.8% | 10.3% | 8.9% | 10.4% | 10.0% |
| Operating Income | 31.9M | 26.32M | 17.81M | 20M | 18.73M |
| Operating Margin | 10.2% | 8.4% | 6.8% | 8.0% | 7.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.51M | 3.78M | 5.35M | 2.3M | 836K |
| Other Income / Expenses | (1.35M) | (3.7M) | (5.32M) | (2.23M) | (705K) |
| Income Before Tax | 30.55M | 22.61M | 12.49M | 17.78M | 18.02M |
| Pre-Tax Margin | 9.7% | 7.2% | 4.7% | 7.1% | 7.5% |
| Income Tax Expense | 6.14M | 4.63M | 2.66M | 4.79M | 4.32M |
| Net Income | 24.41M | 17.99M | 9.83M | 12.99M | 13.7M |
| Net Margin | 7.8% | 5.7% | 3.7% | 5.2% | 5.7% |
| EPS (Basic) | 1.78 | 1.33 | 0.72 | 0.94 | 1.00 |
| EPS (Diluted) | 1.76 | 1.31 | 0.71 | 0.92 | 0.99 |
| Weighted Avg Shares | 13.75M | 13.57M | 13.71M | 13.88M | 13.75M |
| Weighted Avg Shares (Diluted) | 13.87M | 13.69M | 13.9M | 14.03M | 13.86M |
Escalade, Incorporated
NASDAQ:ESCA
Intrinsic Alpha fair value
Locked
Current Price
$21.61
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.